MedTrace Logo

Addition of Homeopathy in Patients With Resistant Arterial Hypertension

NCT02124473 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2014-04-28

No results posted yet for this study

Summary

Resistant hypertension (RHTN) is a common clinical problem faced by both primary care clinicians and specialists worldwide. Patients with RHTN have higher rates of cardiovascular events and mortality compared with patients with more easily controlled hypertension. In addition, RHTN is often complicated by metabolic abnormalities.

Homeopathy, although widely used in hypertension, but no study has been taken to evaluate the impact on resistant hypertension. The aim of this trial was to evaluate individualized homeopathy on BP in patients with resistant hypertension.

Conditions

  • Hypertension, Resistant to Conventional Therapy

Interventions

OTHER

Homeopathy

OTHER

Placebo

Sponsors & Collaborators

  • NMP Medical Research Institute

    collaborator OTHER

  • Macmillan Research Group UK

    lead INDUSTRY

Principal Investigators

  • Vipin Sharma, BHMS · NMP Medical Research Institute, India

  • Neha Sharma · Macmillan Research Group UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-01-31
Completion
2014-03-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02124473 on ClinicalTrials.gov